79286-87-6 Usage
Uses
Used in Pharmaceutical Synthesis:
3-(N-Acetyl-N-methylamino)pyrrolidine is used as a key intermediate in the synthesis of various pharmaceuticals and organic compounds. Its unique structure allows for the creation of a wide range of molecules with potential therapeutic properties.
Used in Organic Chemistry:
3-(N-Acetyl-N-methylamino)pyrrolidine serves as a building block in the creation of other complex organic molecules. Its ability to form various chemical bonds makes it a valuable component in the development of new organic compounds with diverse applications.
Used in Research and Development Laboratories:
3-(N-Acetyl-N-methylamino)pyrrolidine is primarily used in research and development laboratories due to its versatile reactivity. Scientists and chemists leverage its properties to explore new chemical reactions, synthesize novel compounds, and advance drug discovery and chemical synthesis processes.
Check Digit Verification of cas no
The CAS Registry Mumber 79286-87-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,2,8 and 6 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 79286-87:
(7*7)+(6*9)+(5*2)+(4*8)+(3*6)+(2*8)+(1*7)=186
186 % 10 = 6
So 79286-87-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H14N2O/c1-6(10)9(2)7-3-4-8-5-7/h7-8H,3-5H2,1-2H3
79286-87-6Relevant academic research and scientific papers
BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS
-
Page/Page column 43, (2009/07/17)
The invention provides novel bis-pyridylpyridones which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), pharmaceutical compositions containing them, processes for their preparation, and their use in therapy and for the treatment of obesity and/or diabetes.
Antibacterial 7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives
-
, (2008/06/13)
The present invention relates to a 1,8-naphthyridine derivative of the formula STR1 wherein R1, R2 and R3 are the same or different and each hydrogen or lower alkyl having 1 to 5 carbon atoms; and esters thereof and salts thereof and processes for preparation thereof. These compounds show excellent antibacterial activity and are useful antibacterial agents.